Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

435.62
+3.620.84%
Post-market: 435.620.00000.00%17:05 EST
Volume:217.95K
Turnover:94.43M
Market Cap:9.99B
PE:-33.90
High:438.73
Open:430.23
Low:421.45
Close:432.00
52wk High:615.00
52wk Low:265.00
Shares:22.94M
Float Shares:11.00M
Volume Ratio:0.53
T/O Rate:1.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8501
EPS(LYR):-12.8501
ROE:-42.49%
ROA:-16.30%
PB:16.58
PE(LYR):-33.90

Loading ...

Madrigal Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Madrigal Pharmaceuticals initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Madrigal Pharmaceuticals Lobbying And Insider Sales Put Valuation In Focus

Simply Wall St.
·
Jan 27

Can Trump and Big Pharma Get the World to Pay More for Drugs? -- Heard on the Street -- WSJ

Dow Jones
·
Jan 25

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 23

Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer License For Ervogastat In MASH Therapy Combinations

Simply Wall St.
·
Jan 23

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 22

U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix

Reuters
·
Jan 21

Top Madrigal Pharmaceuticals Insiders Quietly Cash In On Shares

TIPRANKS
·
Jan 21

Madrigal Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Rita Thakkar

Reuters
·
Jan 21

Madrigal Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jan 20

Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens

TIPRANKS
·
Jan 20

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer Partnership In Metabolic Liver Disease

Simply Wall St.
·
Jan 16

Director Paul A. Friedman Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares

Reuters
·
Jan 14

Director Rebecca Taub Reports Disposal of Madrigal Pharmaceuticals Inc. Common Shares

Reuters
·
Jan 14

U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard

Reuters
·
Jan 12

Madrigal Pharmaceuticals Inc : TD Cowen Raises Target Price to $644 From $554

THOMSON REUTERS
·
Jan 12

Roblox, First Solar, And League Enterprise Are Among Top 10 Large Cap Losers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?

Benzinga_recent_news
·
Jan 12

Madrigal Pharmaceuticals Secures Global License for Ervogastat from Pfizer

Reuters
·
Jan 09

Madrigal Pharmaceuticals Inc - Plans Drug-to-Drug Interaction Study With Rezdiffra

THOMSON REUTERS
·
Jan 09